Skip to content
Investing

Ionic Rare Earths Profile: Belfast Magnet Recycling, Makuutu and a Thin Cash Cushion

Ionic Rare Earths recycles magnets into rare earth oxides at a Belfast demonstration plant, but it ended September with only A$5.1m in cash, enough for little more than one quarter.

A worker in a high-visibility vest working on process equipment inside a plant enclosure
Photo: Ionic Rare Earths

Ionic Rare Earths wants to become a Western supplier of the rare earth oxides used in permanent magnets, mainly by recycling old magnets in Belfast. It has working technology at demonstration scale, partners in the US and Brazil, and a large clay deposit in Uganda. What it lacks is money: it ended September with A$5.1m in cash, enough for little more than one quarter at its current spending.

What the Company Does

Ionic Rare Earths (IonicRE) is based in Melbourne and listed on the ASX as IXR. It is quoted in the US on the OTCQB as IXRRF and is preparing a second listing on London's AIM market. Its business has four parts.

  • Ionic Technologies, Belfast (100%): a magnet recycling and rare earth refining business with a demonstration plant in Northern Ireland.
  • US Strategic Metals joint venture (proposed 50%): a planned recycling venture in Missouri, still under negotiation.
  • Viridion, Brazil (50%): a joint venture with Viridis Mining and Minerals to build a rare earth refining and recycling centre at Poços de Caldas.
  • Makuutu, Uganda (60%): a large ionic adsorption clay deposit rich in heavy rare earths, now under strategic review.

Rare earth magnets, made from neodymium, praseodymium, dysprosium and terbium, go into electric motors, wind turbines and defence equipment. China dominates their supply and has restricted exports, which has driven Western governments to fund alternatives.

Ionic Rare Earths: share price, chart and news

A laboratory technician in a white coat pipetting samples next to an analytical instrument.
A laboratory technician in a white coat pipetting samples next to an analytical instrument. Photo: Ionic Rare Earths

Belfast: From Demonstration to Commercial Plant

The Belfast demonstration plant takes in end-of-life magnets and swarf, the scrap from magnet making, and turns them into separated rare earth oxides. IonicRE says more than 30 feedstock types have been processed and that magnet pre-treatment ran at its nameplate rate of 30 tonnes of magnets a year during 2026. A £600,000 upgrade completed in the September quarter raised the heavy rare earth separation circuit to about two tonnes a year of separated dysprosium and terbium. About four tonnes of mixed oxide were stockpiled for processing.

The commercial plant is planned for Queen's Island in Belfast Harbour. IonicRE submitted a full planning application to Belfast City Council on 19 September and expects a decision in the first quarter of 2027. Tenova Advanced Technologies is carrying out the front-end engineering design, with basic engineering due by the second quarter of 2027 and construction pencilled in from the third quarter. The UK government has made an offer in principle of a £12m capital grant through the Automotive Transformation Fund, which depends on a full funding package being in place.

IonicRE also supplies neodymium-praseodymium and dysprosium oxides to US-based Advanced Magnet Lab for a magnet qualification programme under a US Defense Logistics Agency contract.

Partners Abroad and the Makuutu Review

In September IonicRE's US subsidiary signed a non-binding term sheet with US Strategic Metals (USSM) for a 50-50 joint venture at USSM's permitted site near Fredericktown, Missouri. The plan is for US$100m of funding for initial recycling plants: US$95m from USSM and US$5m of equity split equally. Ionic Technologies would license its technology non-exclusively, and IonicRE would lead technical work and source feedstock. Definitive agreements are targeted by the end of 2026.

In Brazil, Viridion is designing a recycling and refining centre on land granted by the municipality of Poços de Caldas. Belfast is testing a mixed rare earth carbonate sample from Viridis's Colossus project to support a planned scoping study.

In Uganda, Makuutu has a mineral resource of 617 million tonnes at 630 parts per million total rare earth oxides, 517 million tonnes of it in the indicated category, and a definitive feasibility study from March 2023. Its product basket is about 45% medium and heavy rare earths. In July IonicRE launched a strategic review that could bring in strategic or government-backed partners, new structures or a listing elsewhere. No decision has been made. A mining licence application over part of the ground is in progress.

The Numbers

Latest figures

  • A$5.1m cash at 30 September 2026
  • A$14.9m loss for the year to June 2026
  • 257.5m shares on issue at 7 October 2026

IonicRE has no meaningful revenue. Its loss widened to A$14.9m in the year to June from A$11.3m. In the September quarter operating activities used A$4.0m and it spent A$1.5m on plant and equipment, largely funded by the A$8m placement at A$0.26 a share completed in August, which included A$2m from US investor Argentem Creek Partners.

Using the ASX's standard formula, its cash covered about 1.26 quarters of operating outflows. The company says it is evaluating funding options and expects a capital raise to succeed, subject to market conditions. It consolidated its shares 1-for-30 in December 2025. Its meeting notice put the closing price on 7 October at A$0.63, implying a market value of about A$162m.

At the annual meeting on 13 November all resolutions passed, including a change to the constitution for the AIM listing and the issue of placement shares to four directors, who had committed A$0.5m to the August placement subject to shareholder approval. But 27.5% of votes cast went against the remuneration report, a first strike under Australian company law.

MeasureFigure
Operating cash outflow, September quarterA$4.0m
Estimated quarters of funding1.26
Makuutu resource617 Mt at 630 ppm TREO
UK grant offer in principle£12m

Main risks

  • Funding and dilution: with about one quarter of cash, the company says it expects to complete an equity raise, and the Belfast plant needs far more capital
  • Execution: the commercial plant still needs planning consent, a funding package and a final investment decision
  • Deals not yet binding: the USSM joint venture and the outcome of the Makuutu review are uncertain
  • Scale-up: results from a demonstration plant may not carry over to commercial volumes
  • Jurisdiction and permits: Makuutu is in Uganda and its mining licence application is pending
  • Governance: a second strike on pay at next year's meeting could trigger a vote on spilling the board

What to Watch

WhenWhat
Q4 2026Targeted AIM admission and a Belfast funding package update
Q4 2026Planned award of pre-final-investment-decision contracts
End of 2026Target for definitive USSM joint venture agreements
Q1 2027Expected Belfast planning decision; Nth Cycle piloting in Belfast
Q2 2027Completion of basic engineering for the Belfast plant
Q3 2027Planned start of construction, if funded

IonicRE has more partners and plans than money. The next few months will show whether it can fund Belfast, and how much existing shareholders are diluted in the process.

Sources

Related stories

Business

Ionic Rare Earths Plans a London AIM Listing Alongside the ASX by the End of 2026

Ionic Rare Earths, which is developing a magnet recycling plant in Belfast, has hired Peel Hunt and Canaccord Genuity and is targeting admission to London's AIM market in the…

Investing

Energy Fuels Sells Uranium at $88.90 a Pound as Its Rare Earth Push Gathers Pace

Energy Fuels sold uranium at $88.90 a pound in the third quarter, lifting revenue to $29.2m from $17.7m, while paper losses widened its net loss. Its Donald rare earth project is…

Investing

NioCorp Sells All Planned Elk Creek Output and Wins US EXIM Backing for 65% of Costs

NioCorp has sold all planned Elk Creek output to Traxys and ThyssenKrupp, and the US Export-Import Bank aims to lend about 65% of the project's $1.85bn upfront cost, subject to due…

Investing

Ondas Investor Profile: A Fast-Buying Drone and Defence Group Aiming for $1.1bn in Sales

Ondas has bought its way into defence, from ULTRA surveillance aircraft to counter-drone systems. A look at its record $167.5m quarter, $835m backlog, 55% rise in share count and…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…